CClinicalTrials.gg
CompletedNCT06073197Updated Oct 10, 2023

Comparison of Erector Spinae Block and Combined Deep and Superficial Serratus Anterior Plane Block

An interventional study of erector spinae plane block and combined deep and superficial serratus anterior plane block in Analgesia, Pain, Postoperative and Thoracic, sponsored by Uludag University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-10-10.

Sponsored by Uludag University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Jul 2020, registered Sep 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Objective: The authors hypothesized that combined deep and superficial serratus anterior plane block (SAPB) is as effective as erector spinae plane block (ESPB) for intraoperative and postoperative analgesia for video-assisted thoracoscopic surgery.

Design: A prospective randomized controlled study. Participants: Adult patients undergoing elective video-assisted thoracoscopic surgery.

Interventions: Preoperative SAPB or ESPB implementation.

Read the detailed description

Plane blocks implemented on preoperative course on 35 patients for each group. Postoperative Visual Analogue Scale (VAS) scores (0-10), intraoperative and postoperative analgesic consumption was measured using Mann-Whitney test. In the postoperative phase, opioid side effects, complications related to plane blocks, mobilization time and length of hospital stay was recorded and measured.

02

Conditions studied

  • Analgesia
  • Pain, Postoperative
  • Thoracic
  • Anesthesia

Browse trials for

Keywords

  • serratus anterior plane block
  • video-assisted thoracoscopic surgery
  • erector spinae block
  • postoperative analgesia
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,137 are open to participants now.

This study's enrollment of 70 is close to the median of 75 across 4,341 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Uludag University is the lead sponsor of 141 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anaesthesiologists (ASA) classification I-II scheduled for elective VATS

Exclusion criteria

Exclusion Criteria:

  • Patients who did not give consent
  • Local anaesthetic allergy
  • Known or suspected coagulopathy
  • İnfection at the injection site
  • History of thoracic surgery
  • Severe cardiovascular disease
  • Hepatic or renal insufficiency (glomerular filtration rate \<15 ml/min/1.73 m2)
  • Severe neurological or psychiatric disorders
  • Chronic opioid use
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Active comparator
    erector spinae plane block

    Plane blocks implemented on preoperative course on 35 patients for group.

    Procedure: erector spinae plane block

  • Active comparator
    combined deep and superficial serratus anterior plane block

    Plane blocks implemented on preoperative course on 35 patients for group.

    Procedure: combined deep and superficial serratus anterior plane block

Interventions

  • Procedureerector spinae plane block

    Erector spinae plane block was implemented on preoperative course on 35 patients. Intraoperative analgesic (Fentanyl) consumption was measured for intraoperative effects of the erector spinae plane block. Postoperative Visual Analogue Scale (VAS, from 0 to 10) scores and postoperative analgesic (Morphine) consumption was measured using Mann-Whitney test.

  • Procedurecombined deep and superficial serratus anterior plane block

    Combined deep and superficial serratus anterior plane block was implemented on preoperative course on 35 patients. Intraoperative analgesic (Fentanyl) consumption was measured for intraoperative effects of the erector spinae plane block Postoperative Visual Analogue Scale (VAS, from 0 to 10) scores and postoperative analgesic (Morphine) consumption was measured using Mann-Whitney test.

06

What researchers measure

Primary outcomes

  1. postoperative analgesic effects

    The primary outcome is compare the postoperative analgesic effects of SAPB and ESPB applied under USG guidance before surgery in patients scheduled for VATS using VAS (Visual Analogue Scale from 0 to 10).

    Time frame: first 48 hours

  2. intraoperative analgesic effects

    The primary outcome is compare the intraoperative analgesic effects of SAPB and ESPB applied under USG guidance before surgery in patients scheduled for VATS by measuring perioperative fentanyl consumption in both groups.

    Time frame: intraoperative phase

Secondary outcomes

  1. side effects

    The secondary aim was to compare the opioid side effects. Patients were informed about opioid side effects and asked whether side effects were present.

    Time frame: first 48 hours

  2. complications

    The secondary aim was to compare the complications related to the applied block. Patients were examined and evaluated for any complications related to the block.

    Time frame: first 48 hours

  3. mobilization

    The secondary aim was to compare the mobilization time

    Time frame: first 48 hours

  4. stay of hospital

    length of stay in the recovery unit and hospital

    Time frame: first 4 days

07

Study locations

1 site
  • Bursa Uludag University
    Bursa, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06073197
Lead sponsor
Uludag University
Responsible party
Seda Cansabuncu (medical doctor, Uludag University) — Principal investigator
First posted
Oct 10, 2023
Start date
Jul 2, 2020
Primary completion
Feb 25, 2021
Completion
Feb 25, 2021
Last update
Oct 10, 2023

Study contacts

seda cansabuncu
study chair · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion